Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04731935 · ClinicalTrials.gov registry record · NA
Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal
A NA study, sponsored by Spark Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04731935 is a NA study that has completed, run by Spark Biomedical. The registered enrollment target is 6 participants.
The verdict
NCT04731935, a NA study, has completed, sponsored by Spark Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate whether tAN via the tragus (vagal) and auriculotemporal (trigeminal) nerve pathways results in a clinically meaningful reduction in opioid withdrawal symptoms.
Interventions
- DEVICE Sparrow Therapy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-03-18 |
| Est. Completion | 2021-05-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04731935
The ClinicalTrials.gov registry entry for NCT04731935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spark Biomedical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sparrow Therapy System is the first listed.
NCT04731935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04731935 about?
NCT04731935 is a clinical study titled "Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal". The objective of this study is to evaluate whether tAN via the tragus (vagal) and auriculotemporal (trigeminal) nerve pathways results in a clinically meaningful reduction in opioid withdrawal symptoms.
What is the current status of trial NCT04731935?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-03-18. Estimated completion is 2021-05-26.
What interventions are being tested in trial NCT04731935?
The interventions under investigation include: Sparrow Therapy System (DEVICE).
Who is sponsoring clinical trial NCT04731935?
This trial is sponsored by Spark Biomedical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.